ALZCHEM GROUP AG (ACT.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:ACT - DE000A2YNT30 - Common Stock
167.5 EUR
+3.5 (+2.13%)
Taking everything into account, ACT scores 7 out of 10 in our fundamental rating. ACT was compared to 69 industry peers in the Chemicals industry. ACT scores excellent points on both the profitability and health parts. This is a solid base for a good stock. ACT is valied quite expensively at the moment, while it does show a decent growth rate. These ratings could make ACT a good candidate for quality investing.
1. Profitability
1.1 Basic Checks
- In the past year ACT was profitable.
- In the past year ACT had a positive cash flow from operations.
- In the past 5 years ACT has always been profitable.
- ACT had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
- ACT's Return On Assets of 10.49% is amongst the best of the industry. ACT outperforms 95.65% of its industry peers.
- Looking at the Return On Equity, with a value of 26.47%, ACT belongs to the top of the industry, outperforming 95.65% of the companies in the same industry.
- The Return On Invested Capital of ACT (13.45%) is better than 92.75% of its industry peers.
- The Average Return On Invested Capital over the past 3 years for ACT is significantly above the industry average of 6.70%.
- The 3 year average ROIC (12.06%) for ACT is below the current ROIC(13.45%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.49% | ||
| ROE | 26.47% | ||
| ROIC | 13.45% |
ROA(3y)8.81%
ROA(5y)7.86%
ROE(3y)22.87%
ROE(5y)25.91%
ROIC(3y)12.06%
ROIC(5y)10.63%
1.3 Margins
- The Profit Margin of ACT (10.97%) is better than 84.06% of its industry peers.
- ACT's Profit Margin has improved in the last couple of years.
- ACT has a Operating Margin of 15.93%. This is amongst the best in the industry. ACT outperforms 84.06% of its industry peers.
- In the last couple of years the Operating Margin of ACT has grown nicely.
- ACT has a better Gross Margin (66.55%) than 97.10% of its industry peers.
- ACT's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 15.93% | ||
| PM (TTM) | 10.97% | ||
| GM | 66.55% |
OM growth 3Y17.53%
OM growth 5Y12.4%
PM growth 3Y14.29%
PM growth 5Y15.31%
GM growth 3Y2.01%
GM growth 5Y1.44%
2. Health
2.1 Basic Checks
- ACT has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
- The number of shares outstanding for ACT has been reduced compared to 1 year ago.
- Compared to 5 years ago, ACT has less shares outstanding
- The debt/assets ratio for ACT has been reduced compared to a year ago.
2.2 Solvency
- An Altman-Z score of 5.20 indicates that ACT is not in any danger for bankruptcy at the moment.
- ACT has a better Altman-Z score (5.20) than 89.86% of its industry peers.
- ACT has a debt to FCF ratio of 1.32. This is a very positive value and a sign of high solvency as it would only need 1.32 years to pay back of all of its debts.
- ACT's Debt to FCF ratio of 1.32 is amongst the best of the industry. ACT outperforms 94.20% of its industry peers.
- ACT has a Debt/Equity ratio of 0.16. This is a healthy value indicating a solid balance between debt and equity.
- ACT's Debt to Equity ratio of 0.16 is fine compared to the rest of the industry. ACT outperforms 75.36% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.16 | ||
| Debt/FCF | 1.32 | ||
| Altman-Z | 5.2 |
ROIC/WACC1.84
WACC7.31%
2.3 Liquidity
- A Current Ratio of 2.87 indicates that ACT has no problem at all paying its short term obligations.
- With an excellent Current ratio value of 2.87, ACT belongs to the best of the industry, outperforming 82.61% of the companies in the same industry.
- ACT has a Quick Ratio of 1.77. This is a normal value and indicates that ACT is financially healthy and should not expect problems in meeting its short term obligations.
- The Quick ratio of ACT (1.77) is better than 81.16% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.87 | ||
| Quick Ratio | 1.77 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an impressive 24.12% over the past year.
- The Earnings Per Share has been growing by 24.60% on average over the past years. This is a very strong growth
- The Revenue has been growing slightly by 1.05% in the past year.
- ACT shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.06% yearly.
EPS 1Y (TTM)24.12%
EPS 3Y25.02%
EPS 5Y24.6%
EPS Q2Q%31.66%
Revenue 1Y (TTM)1.05%
Revenue growth 3Y9.49%
Revenue growth 5Y8.06%
Sales Q2Q%6.46%
3.2 Future
- Based on estimates for the next years, ACT will show a very strong growth in Earnings Per Share. The EPS will grow by 20.26% on average per year.
- Based on estimates for the next years, ACT will show a small growth in Revenue. The Revenue will grow by 6.02% on average per year.
EPS Next Y19.46%
EPS Next 2Y14.69%
EPS Next 3Y19.01%
EPS Next 5Y20.26%
Revenue Next Year2.51%
Revenue Next 2Y5.13%
Revenue Next 3Y8.61%
Revenue Next 5Y6.02%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- A Price/Earnings ratio of 27.46 indicates a quite expensive valuation of ACT.
- ACT's Price/Earnings ratio is in line with the industry average.
- ACT is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 26.94, which is the current average of the S&P500 Index.
- With a Price/Forward Earnings ratio of 25.00, ACT can be considered very expensive at the moment.
- Based on the Price/Forward Earnings ratio, ACT is valued a bit more expensive than the industry average as 62.32% of the companies are valued more cheaply.
- ACT is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 23.94, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 27.46 | ||
| Fwd PE | 25 |
4.2 Price Multiples
- ACT's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. ACT is more expensive than 60.87% of the companies in the same industry.
- ACT's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 48.74 | ||
| EV/EBITDA | 14.09 |
4.3 Compensation for Growth
- The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
- The excellent profitability rating of ACT may justify a higher PE ratio.
- A more expensive valuation may be justified as ACT's earnings are expected to grow with 19.01% in the coming years.
PEG (NY)1.41
PEG (5Y)1.12
EPS Next 2Y14.69%
EPS Next 3Y19.01%
5. Dividend
5.1 Amount
- With a Yearly Dividend Yield of 1.12%, ACT has a reasonable but not impressive dividend return.
- ACT's Dividend Yield is slightly below the industry average, which is at 2.33.
- Compared to the average S&P500 Dividend Yield of 1.83, ACT is paying slightly less dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.12% |
5.2 History
- The dividend of ACT has a limited annual growth rate of 6.00%.
Dividend Growth(5Y)6%
Div Incr Years5
Div Non Decr Years5
5.3 Sustainability
- ACT pays out 49.16% of its income as dividend. This is a bit on the high side, but may be sustainable.
- The dividend of ACT is growing, but earnings are growing more, so the dividend growth is sustainable.
DP49.16%
EPS Next 2Y14.69%
EPS Next 3Y19.01%
FRA:ACT (1/20/2026, 5:29:57 PM)
167.5
+3.5 (+2.13%)
Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)10-30 2025-10-30
Earnings (Next)02-27 2026-02-27/amc
Inst Owners40.91%
Inst Owner ChangeN/A
Ins Owners28%
Ins Owner ChangeN/A
Market Cap1.71B
Revenue(TTM)563.86M
Net Income(TTM)61.84M
Analysts86
Price Target180.48 (7.75%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.12% |
Yearly Dividend1.2
Dividend Growth(5Y)6%
DP49.16%
Div Incr Years5
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)13.82%
PT rev (3m)11.74%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)1.01%
EPS NY rev (3m)1.72%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.31%
Revenue NY rev (3m)-0.37%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 27.46 | ||
| Fwd PE | 25 | ||
| P/S | 3.02 | ||
| P/FCF | 48.74 | ||
| P/OCF | 11.71 | ||
| P/B | 7.3 | ||
| P/tB | 7.41 | ||
| EV/EBITDA | 14.09 |
EPS(TTM)6.1
EY3.64%
EPS(NY)6.7
Fwd EY4%
FCF(TTM)3.44
FCFY2.05%
OCF(TTM)14.3
OCFY8.54%
SpS55.39
BVpS22.95
TBVpS22.6
PEG (NY)1.41
PEG (5Y)1.12
Graham Number56.13
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.49% | ||
| ROE | 26.47% | ||
| ROCE | 18.66% | ||
| ROIC | 13.45% | ||
| ROICexc | 16.12% | ||
| ROICexgc | 16.26% | ||
| OM | 15.93% | ||
| PM (TTM) | 10.97% | ||
| GM | 66.55% | ||
| FCFM | 6.21% |
ROA(3y)8.81%
ROA(5y)7.86%
ROE(3y)22.87%
ROE(5y)25.91%
ROIC(3y)12.06%
ROIC(5y)10.63%
ROICexc(3y)13.35%
ROICexc(5y)11.55%
ROICexgc(3y)13.5%
ROICexgc(5y)11.66%
ROCE(3y)16.73%
ROCE(5y)14.74%
ROICexgc growth 3Y25.57%
ROICexgc growth 5Y18.04%
ROICexc growth 3Y25.41%
ROICexc growth 5Y17.9%
OM growth 3Y17.53%
OM growth 5Y12.4%
PM growth 3Y14.29%
PM growth 5Y15.31%
GM growth 3Y2.01%
GM growth 5Y1.44%
F-Score6
Asset Turnover0.96
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.16 | ||
| Debt/FCF | 1.32 | ||
| Debt/EBITDA | 0.33 | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 125.34% | ||
| Profit Quality | 56.58% | ||
| Current Ratio | 2.87 | ||
| Quick Ratio | 1.77 | ||
| Altman-Z | 5.2 |
F-Score6
WACC7.31%
ROIC/WACC1.84
Cap/Depr(3y)118.98%
Cap/Depr(5y)119.68%
Cap/Sales(3y)5.65%
Cap/Sales(5y)6.26%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)24.12%
EPS 3Y25.02%
EPS 5Y24.6%
EPS Q2Q%31.66%
EPS Next Y19.46%
EPS Next 2Y14.69%
EPS Next 3Y19.01%
EPS Next 5Y20.26%
Revenue 1Y (TTM)1.05%
Revenue growth 3Y9.49%
Revenue growth 5Y8.06%
Sales Q2Q%6.46%
Revenue Next Year2.51%
Revenue Next 2Y5.13%
Revenue Next 3Y8.61%
Revenue Next 5Y6.02%
EBIT growth 1Y16.7%
EBIT growth 3Y28.68%
EBIT growth 5Y21.47%
EBIT Next Year50.25%
EBIT Next 3Y28.31%
EBIT Next 5Y19.11%
FCF growth 1Y37.23%
FCF growth 3Y62.42%
FCF growth 5Y94.14%
OCF growth 1Y166.77%
OCF growth 3Y34.7%
OCF growth 5Y19.23%
ALZCHEM GROUP AG / ACT.DE FAQ
Can you provide the ChartMill fundamental rating for ALZCHEM GROUP AG?
ChartMill assigns a fundamental rating of 7 / 10 to ACT.DE.
What is the valuation status for ACT stock?
ChartMill assigns a valuation rating of 3 / 10 to ALZCHEM GROUP AG (ACT.DE). This can be considered as Overvalued.
Can you provide the profitability details for ALZCHEM GROUP AG?
ALZCHEM GROUP AG (ACT.DE) has a profitability rating of 9 / 10.
Can you provide the financial health for ACT stock?
The financial health rating of ALZCHEM GROUP AG (ACT.DE) is 9 / 10.
What is the earnings growth outlook for ALZCHEM GROUP AG?
The Earnings per Share (EPS) of ALZCHEM GROUP AG (ACT.DE) is expected to grow by 19.46% in the next year.